Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Japan Hepatitis C Settlement Set To Cover Only 10 Percent

This article was originally published in PharmAsia News

Executive Summary

The Japanese government settlement with hepatitis C patients, set for Osaka High Court review Feb. 7, is likely to cover only 10 percent of those infected, according to a plaintiff lawyer. The lawyer said the others have not been able to prove the source of their infection and probably will not be covered. The cases were linked to blood products provided by Mitsubishi Tanabe Pharma, but many patient records were destroyed before a connection could be determined. Mitsubishi Tanabe's Green Cross unit, a defendant in one suit, is to share in the settlement payout. (Click here for more

Related Content




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts